ArticlePLoS biology2019
Late-life mortality is underestimated because of data errors.
Article in PLoS biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- The global response to the pandemic: An empirical cluster analysis of policies targeting COVID-19.PloS one · 2025Article
- Identification of a "Blue Zone" in the Netherlands: A Genetic, Personal, Sociocultural, and Environmental Profile.The Gerontologist · 2024Article
- An underappreciated peculiarity of late-life human mortality kinetics assessed through the lens of a generalization of the Gompertz-Makeham law.Biogerontology · 2024Article
- Trend of incidence rate of age-related diseases: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database in Korea: a cross- sectional study.BMC geriatrics · 2023Article
- Early-life physical performance predicts the aging and death of elite athletes.Science advances · 2023Article
- What Is an Aging-Related Disease? An Epidemiological Perspective.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022Article
- Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan.Nature aging · 2022Review
- Human mortality at extreme age.Royal Society open science · 2021Article
- The degree of frailty as a translational measure of health in aging.Nature aging · 2021Review
- Comparative analysis of completeness of death registration, adult mortality and life expectancy at birth in Brazil at the subnational level.Population health metrics · 2020Article
- Are We Approaching a Biological Limit to Human Longevity?The journals of gerontology. Series A, Biological sciences and medical sciences · 2020Article
- A universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories.Scientific reports · 2019Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Knowledge of true mortality trajectory at extreme old ages is important for biologists who test their theories of aging with demographic data. Studies using both simulation and direct age validation found that longevity records for ages 105 years and older are often incorrect and may lead to spurious mortality deceleration and mortality plateau. After age 105 years, longevity claims should be considered as extraordinary claims that require extraordinary evidence. Traditional methods of data cleaning and data quality control are just not sufficient. New, more strict methodologies of data quality control need to be developed and tested. Before this happens, all mortality estimates for ages above 105 years should be treated with caution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.